WallStreetZenWallStreetZen

NYSEMKT: TOVX
Theriva Biologics Inc Stock Ownership - Who owns Theriva Biologics?

OverviewEarningsDividendOwnership

Insider buying vs selling

Have Theriva Biologics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Steven A. ShallcrossCEO and CFO2023-06-0714,000$0.69
$9.70kBuy
Steven A. ShallcrossCEO and CFO2023-06-0626,000$0.63
$16.46kBuy

1 of 1

TOVX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TOVX insiders and whales buy or sell their stock.

TOVX Shareholders

What type of owners hold Theriva Biologics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc2.14%366,580$147.73kInstitution
Steven A. Shallcross1.46%250,000$100.75kInsider
Blackrock Inc1.11%190,060$76.59kInstitution
Geode Capital Management LLC0.82%141,168$56.89kInstitution
Renaissance Technologies LLC0.35%59,210$23.86kInstitution
Citadel Advisors LLC0.34%57,953$23.36kInstitution
State Street Corp0.28%48,691$19.62kInstitution
Jane Street Group LLC0.28%47,559$19.17kInstitution
Virtu Financial LLC0.23%39,121$15.77kInstitution
Bridgeway Capital Management LLC0.17%28,528$11.50kInstitution

1 of 3

TOVX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TOVX6.14%1.46%Net Buying
MYMD46.54%53.46%Net Buying
PULM4.28%95.72%
TRVN7.63%92.37%Net Buying
CLDI5.35%49.17%Net SellingNet Buying
View Top Biotech Stocks

Theriva Biologics Stock Ownership FAQ

Who owns Theriva Biologics?

Theriva Biologics (NYSEMKT: TOVX) is owned by 6.14% institutional shareholders, 1.46% Theriva Biologics insiders, and 92.41% retail investors. Steven A. Shallcross is the largest individual Theriva Biologics shareholder, owning 250,000.00 shares representing 1.46% of the company. Steven A. Shallcross's Theriva Biologics shares are currently valued at $101.50k.

If you're new to stock investing, here's how to buy Theriva Biologics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.